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We evaluated the potential cancer risk to
adults from ingesting polychlorinated
biphenyls (PCBs) in fish and shelfis us
an equilibrium petitioning mol ofPCB
bioaccumelation in the aquatic animal.
Estimated potential cancer risk to humans
increased exponentially with increasing
hydrophobicity ofthe PCB. However, the
addition offood-chain sources ofPCBs was
necessary to cause potential cancer risk to
exceed 106. Environmental degradation of
thePCB reducedcancer riskbyre the
exposure concentration; 3.3 degradation
half-lives required to icer risk
estimates by one order ofmaide. PCB
biotram ation to nongenotoic metabo-
lites (no increase in the cancer slope fiator)
bytheaquatic animal reduced cancer riskby
reducing the steady-state concentrtion of
PCBs in the:edible tissue. E relatively
dowbioa t (e*g, mebichalf-
life of 100 days) reduced cancer. risk esti-
mates under the default model conditions.
Nonequilibrium conditions, such as limited
exposure dtime, r p ial cancer risk
by reducing taminant conception in
the aquatic animal. Risk a ss t using
toxic equivenc factor predie':s.bstan-
tiiygraeposential rsfospcicon- -daly 8 ~edlrisk fiTic. coX.
geners than for PCB mixtures. O alua-
tion demonstrates that deviation from con-
ventional assumptions used in risk assess-
ment (e.g., nqeib bio and
degradation: steady-state equilibrium) can
significantly Atnwer riskestimates y
uords: bi usnulation, b rn,
degadation equibrium par poy-
chlorinated biphenyls, risk a t t
equivalencyfactors. EnvironHealh Pdpect
102:562-567:(1994)
Polychlorinated biphenyls (PCBs) are a
class ofchlorine-substituted aromatics con-
sisting of 209 possible congeners. PCBs
were sold commercially and entered the
environment as various mixtures of indi-
vidual congeners (e.g., Aroclor in the
United States, Kanechlor in Japan). The
physical-chemical properties and toxicity
of PCBs vary with the degree of chlorine
substitution, number ofvicinal unsubsti-
tuted carbons, and steric configuration (1).
PCBs have become significant environ-
mental contaminants because they are per-
sistent, ubiquitous, bioaccumulative, and
potentially carcinogenic. Currently PCBs
are considered to be class B2 carcinogens
because ofsufficient weight ofevidence in
animals (hepatocellular carcinoma), but
inadequate weight of evidence in humans
(2). Although the carcinogenic potency of
PCBs remains uncertain, the assessment of
potential cancer risk of PCBs in environ-
mental media remains a requisite compo-
nent ofrisk assessment (3).
Risk assessment generally involves esti-
mating potential risk from intake rate and
the carcinogenic potency of the chemical.
Estimates ofcarcinogenic potency are pub-
lished as cancer slope factors (3) after eval-
uation of data from animal studies, geno-
toxicity and mutagenicity assays, and epi-
demiologic studies. Intake rates are typically
calculated from the measured concentra-
tion in the edible tissue and normalizing
the dose for body weight and exposure
time using standardized parameter values
and exposure models (3,4). In the absence
of direct measurements, tissue concentra-
tions can be predicted from the chemical
concentration in the environmental media
and pharmacokinetic or equilibrium parti-
tioning models (5). Whether predicted or
measured tissue concentrations are used to
calculate intake, an invariant tissue concen-
tration is usually assumed in estimating
risk.
The objective of the present study was
to evaluate the relationship between esti-
mated cancer risk and factors controlling
PCB concentrations in tissues of aquatic
animals. We evaluated potential cancer risk
from ingestion of PCBs in fish and shell-
fish using a standard oral exposure model
for adults. PCBs in edible tissue were pre-
dicted using an equilibrium partitioning
model of PCB bioaccumulation in the
aquatic animal. The equilibrium partition-
ing model and risk analysis model were
coupled to quantify the effect of PCB
bioaccumulation in fish and shellfish on
estimates of potential cancer risk. Factors
evaluated in this study included PCB
hydrophobicity and food chain contribu-
tions, environmental degradation ofPCBs,
biotransformation by the aquatic animal,
and nonequilibrium exposure conditions.
Additionally, the potential cancer riskfrom
ingestion ofindividual PCB congeners was
assessed because risk is usually assessed
from total concentrations of PCBs rather
than the specific congeners present.
Methods
We predicted PCB concentrations in fish
and shellfish using an equilibrium parti-
tioning model of PCB bioaccumulation in
the aquatic animal (5):
BCF = k1lk2, (1)
where BCF is the ratio ofthe PCB concen-
tration in the aquatic animal to exposure
water at equilibrium, and kl and k2 are
first-order uptake and elimination con-
stants, respectively. Inherent assumptions
of the equilibrium partitioning model
include steady-state conditions, negligible
biotransformation, and contaminant uptake
by the aquatic animal solelyfrom water.
We estimated potential cancer risk
(RISK) to adult humans from ingestion of
PCB-contaminated fish and shellfish using
the reported (6) carcinogenic potency
(cancer slope factor; CSF) and the standard
oral exposure model (3):
RISK= Ix CSF. (2)
Intake (I was calculated from:
I= Cxax IRx EF x ED,
BW xAT
(3)
where default model parameters are
defined in Table 1. The contaminant con-
centration in edible tissue (Cr) was calcu-
lated by applying BCF to the ambient
water concentration (C2,):
Cr=BCFxfxCw. (4)
The edible tissue fraction (f) was included
in Equation 4 to normalize CT to the
PCBs present in tissue ingested by humans
(7).
The relationship between chemical
hydrophobicity and potential cancer risk
was evaluated using BCFs estimated fromthe
relationship between octanol-water parti-
tion coefficient(K0Q) and BCF in fish (8):
BCF = 0.79 x (logKIw) - 0.40. (5)
The effect of PCB bioaccumulation in
aquatic animals from food-chain sources
(trophic transfer) was evaluated by apply-
ing a hydrophobicity-dependent food
chain multiplier (FCM) to the hydropho-
bicity-dependent BCF from Equation 5:
BAF = FCM x BCF. (6)
The calculated bioaccumulation factor
(BAF) was then substituted for BCF (in
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Environmental Health Perspectives 562Table 1. Model parameters and defaultvalues used in estimating potential cancer riskfrom tissue con-
sumption
Definition
Bioconcentration factor
Uptake clearance constant
Elimination rate constant
Cancer slope factor
Concentration in edible tissue
Absorption efficiency
Ingestion rate
Exposure frequency
Exposure duration
Bodyweight
Averaging time
Water concentration
Food chain multiplier
Bioaccumulation factor
Edible tissue fraction
Toxicity equivalency factor
Equation 4) to estimate Cr. FCMs used in
Equation 6 were for the fourth trophic
level (top predators) developed by EPA (9)
from the food chain model of Thomann
(10).
We evaluated the effect ofenvironmen-
tal degradation (e.g., photolysis, hydrolysis,
biodegradation) in determining potential
cancer risk from ingestion of bioaccumu-
lated PCBs by modeling degradation as a
single first-order rate constant (kd). Cr,
which declined over time due to declining
(2w, was calculated by substituting kl and
k2 for BCF (Eq .1):
Cr
= (k,/k2) xfx Cw x e- (7)
We set kd at 0.001, 0.01, or 0.1 day1, cor-
responding to PCB degradation half-lives
of693, 69.3, and 6.93 days, respectively.
PCB biotransformation by the aquatic
animal was modeled as a separate parame-
ter for biotransformation (kM; the meta-
bolic rate constant) to assess the effect on
potential cancer risk. The equation for Cr
substituted kl and k2 for BCF (Eq. 1):
Cr = Cw Xxkl(k2 + kM). (8)
Total elimination was set equal to (k2 +
kM), and kM was varied over the range of
0.0001 to 0.1 day-l (corresponding to half-
lives between 6930 to 6.93 days).
We evaluated the effect of nonequilib-
rium conditions on the potential cancer
risk of PCBs bioaccumulated in fish and
shellfish by calculating Cr with increasing
PCB exposure time (11):
Cr= cwxfx (k /k2) x (1e ); (9)
kl and k2 were substituted for BCF (Eq. 1).
The potential cancer risk resulting
from the ingestion ofindividual PCB con-
geners was estimated by substituting the
congener-specific cancer slope factor
Default
Calculated
700 I x day
0.007 day
7.7 (mg x kg- xday-
Calculated
1
0.0065 kg x day1
350 days x year1
30 years
70kg
25,550 days
0.1 ng/l
From U.S. EPA (9)
Calculated
0.4
From Safe (1)
(CSFSpecifiC) for CSF in Equation 2.
CSFspecific was calculated from:
CSFspecific = CSFTCDD x TEF, (10)
where CSFTCDD [CSF for 2,3,7,8-tetra-
chloro-dibenzo-p-dioxin (TCDD)] was
equal to 1.5 x 105 (12) and the TEFs
(toxic equivalency factors) for individual
congeners were from Safe (1) or Kafafi et al.
(13). The TEF normalizes the potency of
an individual congener to the potency of
TCDD (TEF = 1) (1). Tissue concentra-
tions (Cr) were estimated using the con-
gener-specific hydrophobicity (K0w) from
Hawker and Connell (14) to calculate
BCF (Eq. 5).
Results and Discussion
Model Assumptions
Potential cancer risk from ingestion of
PCBs in fish and shellfish was estimated
using a standard oral exposure model for
adults and the product of carcinogenic
potency and chemical intake. The concen-
tration of PCBs in edible tissue was calcu-
lated from an equilibrium partitioning
model, rather than using measured tissue
concentrations, to evaluate the dependence
of cancer risk estimates on model assump-
tions. Using a fixed cancer slope factor
(Table 1), estimated potential cancer risk
was directly proportional to the predicted
tissue concentration in the aquatic animal.
To calculate tissue concentrations, we
chose representative default conditions
(Table 1) for aquatic animals and PCBs.
The default value for the uptake constant
was 700 1/day, which was in the range of
1-1000 I/day reported for fish by McKim
and Heath (15). The default value for the
elimination constant was 0.007 day-1, cor-
responding to an elimination half-life of99
days. Niimi and Oliver (16) reported that
the elimination half-lives of PCB con-
geners from trout (Oncorhynchus mykiss)
muscle ranged from less than 5 days to 127
days. The edible tissue fraction (f) was
used to adjust PCB concentrations in the
whole body of the aquatic animal to the
edible tissue concentration. The value forf
(0.4) was calculated from the ratio ofPCBs
in muscle to-whole fish of Lake Ontario
salmonids (7) and appeared to vary with
fish species and the congeners present (7).
We used the relationship between
hydrophobicity (Kow) and BCF (8) to esti-
mate tissue concentrations ofPCBs in fish
and shellfish; this relationship was estab-
lished with fish ofa mean lipid content of
7.6% (9). Lipid contents were not normal-
ized for species or trophic level, although
lipid content and composition are variable
in aquatic animals (e.g., 1-10% of tissue
mass), even within a specific tissue (17).
The default water concentration (0.1 ng
PCB/1) was constant (Table 1). This con-
centration is below the range of reported
background water concentrations in
diverse aquatic environments (18) and
approximated the ambient water quality cri-
teria (19) corresponding to 10-6 excess
cancer risk for the ingestion ofPCB conta-
minated fish and shellfish.
The majority of the default assump-
tions of the oral exposure model for adult
humans were conservative and thus may
result in an overestimate ofrisk. For exam-
ple, absorption efficiency in humans was
set at 1 (100% bioavailability), as recom-
mended by EPA (3). However, animal
studies have shown a general trend of
decreasing absorption efficiency for higher
chlorinated congeners (20). Ingestion of
PCB-contaminated fish and shellfish was
assumed to occur for 350 days/year for 30
years (3). Intake was estimated assuming
an average ingestion rate of6.5 g contami-
nated tissue per day, as recommended by
EPA (3). The 6.5 g/day value represents a
national average for populations with a
diversified diet of animal products, while
human populations consuming only conta-
minated fish and shellfish may have inges-
tion rates in excess of 180 g/day (4).
Carcinogenic potency was quantified
using the published CSF for PCBs (6),
with the implicit assumption that all PCB
congeners and mixtures are carcinogenic
and have the same potency. However, the
actual carcinogenic potency of PCB con-
geners and mixtures remains controversial
because ofthe absence ofdirect evidence of
PCB-caused carcinogenesis in humans (2).
PCBs exhibit tumor-promoting activity in
rodents, but do not appear to be mutagenic
or genotoxic. Application ofasingle potency
value may be inappropriate because corn-
mercial mixtures ofPCBs appear to exhibit
differences in carcinogenic potency. For
example, Smith et al. (21) argued that the
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BCF
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k2
CSF
CT
a
IR
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ED
BW
AT
FM
BAF
f
TEF
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PCB mixture Aroclor 1260 is carcinogenic
in animals, but lower-chlorinated Aroclors
(e.g., 1242, 1254) may have limited, if
any, carcinogenicity. Thus, actual cancer
risk from consumption of contaminated
fish and shellfish may be overestimated by
conventional risk assessment methodology.
Bioconcentration
Bioconcentration is the process ofaccumu-
lation of waterborne contaminants by
aquatic organisms through nondietary
routes (22). Predicting PCB bioconcentra-
tion in the edible tissues of fish and shell-
fish from equilibrium partitioning resulted
in increasing potential cancer risk estimates
with increasing chemical hydrophobicity
(Fig. 1). This increase occurred because the
evaluation used a fixed cancer slope factor
(7.7) and assumed equilibrium partition-
ing was the sole process controlling tissue
concentrations. The relationship between
hydrophobicity and potential cancer risk
was evaluated for log KAw between 4 and
6.5 because this range spanned the lower
limit of PCB hydrophobicity (14), and
hydrophobicity may not control biocon-
centration at log Kow greater than 6.5 (9).
Under the default conditions (e.g., water
concentration of 0.1 ng PCB/1), potential
cancer risk was not estimated to exceed 6 10- . Water concentrations in excess of 10
ng PCB/l and log KoW greater than 5.5
would be required to cause potential can-
5 cer risk to exceed 10- . Thus, there appears
to be limited cancer risk from ingestion of
PCB contaminated fish and shellfish when
accumulation is restricted to bioconcentra-
tion.
Cancer risks estimated from predicted
tissue concentrations must be interpreted
with caution because chemical accumula-
tion in aquatic animals does not appear to
be solely dependent on equilibrium parti-
tioning. Evidence includes the dependence
L.OE-O8 _ _
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Figure 1. Relationship between PCB hydrophobicity
and estimated potential cancer risk in humans
consuming contaminated fish. Potential cancer
risk was estimated using fish tissue concentra-
tions calculated using hydrophobicity-dependent
bioconcentration factors (BCF-based risk) or food
chain bioaccumulation factors (BAF-based risk).
of PCB bioconcentration on the fish
species and exposure regime (22), nonlin-
earity ofthe relationship between log BCF
and log Kow for PCBs (23), and large vari-
ation in BCFs for PCB isomers. For exam-
ple, Mackay et al. (24) reported that BCFs
for tetrachlorobiphenyl ranged from 8,900
to 62,000. Bioconcentration may be limit-
ed because of rate-limiting barriers to
uptake imposed by physiological flow
(epithelial blood perfusion, ventilation,
water) limitations, or to diffusive barriers
due to steric hindrance (25). Steric effects,
caused by the orientation ofchlorine atoms
on the biphenyl moiety, appear to be
important in controlling PCB accumula-
tion. For example, chlorine substitution in
the ortho position decreases aryl hydrocar-
bon (Ah) receptor affinity (13) and may
increase elimination (20). BCFs calculated
from PCB hydrophobicity will overesti-
mate cancer risk from ingestion of PCB-
contaminated fish and shellfish if the
assumption of equilibrium partitioning is
violated.
Food Chain Bioaccumulation
For many persistent chemicals, dietary
(food chain) sources ofa contaminant con-
tribute significantly to contaminant con-
centrations in aquatic animals (26). PCBs
enter the aquatic food chain by partition-
ing between algae and water or from filtra-
tion and ingestion of sediment-associated
PCBs by benthic organisms (27-31). Food
chain contributions ofPCBs are the domi-
nant source of PCBs bioaccumulated in
tissues ofaquatic animals in many aquatic
ecosystems (30,32). Thus, the use ofBCFs
alone is inappropriate to estimate potential
cancer risk from PCB ingestion ofcontam-
inated fish and shellfish. A bioaccumula-
tion factor (BAF) or biota-to-sediment fac-
tor (BSF) is required to predict tissue con-
centrations in the absence of measured
concentrations. The BAF or BSF accounts
for exposure from food chain sources and
normalizes concentrations in edible tissue
to concentrations in the ambient water or
sediment, respectively.
BAFs can be estimated from field or
laboratory measurements (assuming equi-
librium conditions) or may be estimated
by applying kinetic models of simplified
food chains. To estimate potential cancer
risk resulting from food chain bioaccumu-
lation, BAFs were calculated from the
product ofBCF and a food chain multipli-
er (FCM). The FCMs used in estimating
potential cancer risk were hydrophobicity
dependent and were for the fourth trophic
level (top predator) (9). This simplistic
approach used generic FCMs developed by
EPA (9) from the food chain model of
Thomann (10). The Thomann model did
not specifically account for accumulation
of sediment-associated PCBs (10). FCMs
developed from the refined Thomann et al.
(30) model were not available.
Greater potential cancer risk was esti-
mated from food-chain-bioaccumulated
PCBs than from bioconcentration alone
(Fig. 1). Food chain bioaccumulation
caused the potential cancer risk estimates
to exceed 10-6 for log Kw >5.5. Potential
cancer risk was not estimated above log
Kow of 6.5 because of high variability in
FCMs (9). Lower cancer risk would be
predicted from ingestion of species at a
lower trophic level (e.g., filter-feeding-
shellfish) because FCMs are lower (9).
When food chain bioaccumulation is
important, application of BCFs alone to
predict tissue concentrations will underes-
timate potential cancer risk from ingestion
of contaminated fish and shellfish. The
trophic level and the feeding behavior of
the ingested species will also be important
determinants ofpotential cancer risk.
Environmental Degradation and
Biotransformation
Conventional assumptions in risk assess-
ment usually include the absence ofsignifi-
cant biotransformation or degradation of
contaminants. However, significant envi-
ronmental degradation (e.g., hydrolysis or
photolysis, biodegradation), or metabolism
(e.g., biotransformation to polar metabo-
lites) of the chemical may result in lower
tissue concentrations in the aquatic animal.
Environmental degradation of PCBs gen-
erally involves dechlorination, chloroben-
zoic acid formation, and ring cleavage
(33,34). Degradation ofPCBs in environ-
mental media may reduce cancer risk by
reducing contaminant concentrations in
the ambient water or sediment (driver
compartment). Evaluations using the
default parameters for PCBs (Table 1)
showed that relatively rapid degradation
(e.g. half-lives <70 days) was necessary to
substantially reduce driver compartment
concentrations and thus reduce potential
cancer risk (Fig. 2). Independent of the
default parameters, the relationship
between driver compartment concentra-
tion (e.g.,C,) and tissue concentration
(Eq. 7) predicted that 3.3 degradation half-
lives were required to reduce potential can-
cer riskby one order ofmagnitude.
Biotransformation of PCBs by aquatic
animals generally proceeds by P450-medi-
ated oxidation of unsubstituted carbon
atoms in non-ortho positions (35).
Biotransformation is favored by vicinal
unsubstituted meta-para carbon atoms and
provides a site for epoxidation (35).
Conjugation ofhydroxylated metabolites is
limited (33). Chlorine substitution at the
meta-para carbon atoms results in "enrich-
ment," whereas ortho-chlorine substitution
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Figure 2. Relationship between the rate of envi-
ronmental degradation (e.g, half-life, t112) of PCBs
and estimated potential cancer risk in humans
consuming contaminated fish.
favors elimination (20). For example,
Tanabe et al. (20) found that the elimina-
tion half-life of trichlorobiphenyl in fish
decreased from 94 days to 3 days with
increasing ortho-chlorine substitution, pre-
sumably due to increased biotransforma-
tion (17). There also appears to be a gen-
eral inverse relationship between the rate of
PCB metabolism and the extent ofchlori-
nation (16).
Biotransformation was modeled as a
first-order rate constant with half-lives
from 7000 to 7 days and assumed transfor-
mation to nongenotoxic metabolites (no
increase in CSF; Fig. 3). Evaluations using
the default conditions (Table 1) indicated
that even slow metabolism (e.g., metabolic
half-life of 100 days) in the aquatic animal
reduced tissue concentrations and substan-
tially reduced potential cancer risk (Fig. 3).
Prior exposure to PCBs and related chemi-
cals will increase the rate ofbiotransforma-
tion by induction of P450 isozymes. For
example, prior PCB exposure to aquatic
animals favors metabolism of coplanar
non-ortho chlorine-substituted congeners
(35). Induction of biotransformation in
the aquatic animal may further reduce
potential cancer risk by reducing PCB con-
centrations in the tissues of aquatic ani-
mals. Carcinogenic metabolites of PCBs
are less likely to be transferred to humans
(36).
Nonequilibrium Conditions
Equilibrium partitioning models (e.g.,
BCF, BAF) are frequently used to estimate
tissue concentrations in aquatic animals.
Cancer risk estimates developed from these
models inherently assume that equilibrium
conditions exist. However, this assumption
is not valid if the exposure conditions do
not allow establishment of a steady-state
equilibrium. Nonequilibrium conditions
may be caused by variations in exposure to
the aquatic animal (e.g., mobile popula-
tion, intermittent discharge, or dilution),
l.OE-05
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Figure 3. Relationship between the rate of PCB bio-
transformation in the aquatic animal (as the meta-
bolic rate constant) and estimated potential cancer
risk in humans consuming contaminated fish.
or variations in chemical uptake or elimina-
tion by the aquatic animals (e.g., changes
in temperature, body size, or biotransfor-
mation).
Under conditions ofconstant chemical
exposure, uptake, and elimination, conta-
minant concentrations in aquatic animals
exhibit an exponential approach to steady-
state equilibrium. The elimination con-
stant ofthe aquatic animal then determines
the exposure time required to reach steady-
state equilibrium (11). Under conditions
ofconstant exposure, 3.3 elimination half-
lives are required to reach 90% of steady
state. For example, with the default para-
meter as 0.007 dayf (t1/2 = 99 days),
approximately 1 year was required to reach
90% of steady state (Fig. 4). A reduction
in exposure time will reduce the estimated
cancer risk (Fig. 4). Aquatic animals with
short life spans relative to the elimination
half-life may never reach steadystate (32).
Potential cancer risk cannot be accu-
rately estimated if the predicted or mea-
sured tissue concentrations are not repre-
sentative of average contaminant concen-
trations in the aquatic animal during the
ingestion period. For example, a seasonal
increase in contaminant exposure may
cause transient increases in tissue concen-
trations; this may be less of a concern for
slowly eliminated chemicals such as PCBs.
Ultimately, pharmacokinetic models cou-
pled to environmental fate models may be
required to more accurately estimate risk
from ingestion ofPCBs in tissues ofaquat-
ic animals.
Congener-specific Risk
Potential cancer risk from PCB ingestion is
usually assessed from total concentrations
of PCBs rather than a congener-specific
analysis. Congener-specific assessment is
important because individual congeners
may preferentially accumulate in aquatic
animals relative to PCBs in the exposure
media. For example, Niimi and Oliver (7)
0 100 2W 300 400 50
PCB Exposure to Fish (days)
Figure 4. Relationship between duration of PCB
exposure to the aquatic animal and estimated
potential cancer risk in humans consuming con-
taminated fish.
found that 10 congeners represented
approximately 52% of the total PCBs in
Lake Ontario salmonids. Oliver and Niimi
(27) observed that the proportion ofhigh-
er-chlorinated congeners increased with
increasing trophic level. Preferential accu-
mulation (enrichment) may be due to bio-
transformation, environmental degrada-
tion, or limited absorption or equilibrium
partitioning of specific congeners. Thus,
cancer risk estimates based on total PCB
concentrations in tissues may be inappro-
priate.
CSF recommended by EPA for evalu-
ating potential cancer risk ofspecific PCB
congeners are not available. However,
CSFs can be estimated for specific PCB
congeners by applying TEFs, which nor-
malize the potency of an individual con-
gener to the potency of 2,3,7,8-tetra-
chloro-dibenzo-p-dioxin (1). Safe (1) has
estimated TEFs from an integration oftox-
icity, carcinogenicity, and enzyme induc-
tion studies. In general, TEFs are very con-
servative, have large confidence limits, and
are based on both cancer and noncancer
endpoints (1). Thus, interpretation of
potential cancer risk estimated with TEFs
warrants caution.
Application of the TEFs developed by
Safe (1) resulted in potential cancer risk
estimates in excess of10-5 for coplanar and
mono-ortho-substituted coplanar PCB con-
geners (Fig. 5). Ofthe congeners evaluated,
only di-ortho substituted coplanar PCBs
(e.g., congeners 128, 190, 2055) had cancer
risk estimates below 10- (Fig. 5).
Alternatively, application of TEFs devel-
oped from Ah receptor binding (13)
resulted in an order of magnitude lower
estimated risk for the majority of PCB
congeners evaluated (Fig. 6). In compari-
son, potential cancer risk estimates for the
PCB mixture Aroclor 1254 (log Ko, of
4.65) (22) estimated from hydrophobicity
(Fig. 1) was less than 10-7. Potential cancer
risk estimates developed from chemical
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Figure 5. Estimated potential cancer risk in humans consuming contaminated fish for specific PCB con-
geners (identified by congener number). Toxic equivalency factors used in estimated cancer risk (see
text) were from Safe (1).
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Figure 6. Estimated potential cancer risk in humans consuming contaminated fish for specific PCB con-
geners (identified by congener number). Toxic equivalency factors used in estimated cancer risk (see
text) were from Kafafi et al. (13).
hydrophobicity were also limited for other
PCB mixtures. Thus, risk assessment of
PCBs bioaccumulated in fish and shellfish
indicated substantially greater potential
risk from individual congeners than from
the total PCB concentration (37). Specific
PCB congeners may also contribute greater
potential toxicity than other contaminants
bioaccumulated in fish (38). However, the
carcinogenic potency ofspecific PCB mix-
tures or congeners remains uncertain
(2,21). Despite limitations, congener-spe-
cific analysis and application ofTEFs may
eventually improve the risk assessment of
the ingestion of PCBs in tissues ofaquatic
animals.
Conclusions
Tissue concentrations in fish and shellfish
predicted from an equilibrium partitioning
model showed an exponential increase in
potential cancer risk to humanswith increas-
ing hydrophobicity of the PCB. However,
the addition offood-chain sources ofPCBs
were necessary to cause potential cancer
6 risk to exceed 10- . Environmental degra-
dation of PCBs reduced estimated cancer
risk by reducing the aquatic animal expo-
sure concentration. A total of3.3 degrada-
tion half-lives were required to reduce cancer
risk estimates by one order of magnitude.
PCB biotransformation to nongenotoxic
metabolites (no increase in the cancer slope
factor) by the aquatic animal reduced cancer
risk by reducing the steady-state concentra-
tion ofPCBs in the edible tissue. Even rel-
atively slow biotransformation (e.g., meta-
bolic half-life of 100 days) reduced cancer
risk estimates under the default model con-
ditions. Simulations of environmental
degradation and biotransformation did not
account for selective loss or bioaccumula-
tion ofspecific congeners.
Nonequilibrium conditions, such as
limited exposure time, reduced potential
cancer risk by reducing contaminant con-
centrations in the aquatic animal. Risk
assessment using toxic equivalency factors
predicted substantially greater potential
risk for specific congeners than for PCB
mixtures. The evaluation demonstrated
that deviation from conventional assump-
tions used in risk assessment (e.g., negligi-
ble biotransformation and degradation;
steady-state equilibrium) can significantly
affect cancer risk estimates.
The potential cancer risk estimates
developed in this evaluation were specific
to the simulation conditions (i.e., standard
default conditions and PCB-specific para-
meters). However, although the magnitude
of the risk factors were dependent on the
simulation conditions, the observations and
conclusions are intended to have general
applicability. Site-specific and congener-
specific risk estimation may be accom-
plished by integration with more complex
exposure models (e.g., site-specific food
chain model) and risk analysis models.
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